Increasing Access to Biosimilars Act of 2023

Summary

Increasing Access to Biosimilars Act of 2023 This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 3 March 2023

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 3 March 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 3 March 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 10 March 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 15 November 2023

   Committee

   Forwarded by Subcommittee to Full Committee by Voice Vote.

   Source: Committee

6. 15 November 2023

   Committee

   Subcommittee Consideration and Mark-up Session Held

   Source: Committee

7. 5 December 2023

   Committee

   Committee Consideration and Mark-up Session Held

   Source: Committee

8. 6 December 2023

   Vote

   Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.

   Source: Committee

9. 6 December 2023

   Committee

   Committee Consideration and Mark-up Session Held

   Source: Committee

10. 17 December 2024

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 3 March 2023 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 3 March 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 3 March 2023

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 3 March 2023

  Open at official source

Sponsors

• Richard Hudson · R · Sponsor
• · hswm00 · Standing
• · hsif00 · Standing

Related records

• related to ← Increasing Access to Biosimilars Act of 2023